This quantitative analysis informed the subsequent exploration of the qualitative data, which provided in-depth insights into the experiences and patterns associated with using the OBT in therapy
( (iii) If a Part B rebatable biosimilar biological product that is currently in shortage experiences a severe supply chain disruption, CMS will reduce the rebate amount as described in paragraph (b)(1) of this section and will not grant a reduction under 427.401 during those applicable calendar quarters
The NGACO Model evaluation found that while NGACOs reduced gross Medicare Parts A and B expenditures relative to a comparison group of similar fee-for-service Medicare beneficiaries in their markets, they did not generate savings to the Medicare Trust Funds
Several commenters encouraged CMS to consider adopting the same definitions for MDPP as CDC uses for the National DPP, including distance learning, online, and combination modalities to better align MDPP and the National DPP
When you put it in your mouth, you will most likely salivate heavily